Immune System Balancing
[McCulley2018, pg 60] reports that ankylosing spondylitis is an
autoimmune disorder, and proposes an approach to treating this disease, which should be
supervised by a properly trained medical professional.
Dr. Weyrich has considerable interest in this topic, but has
not treated any cases of ankylosing spondylitis
with Immune System Balancing.
Please see What is Immune System Balancing?
for more information.
Low Dose Naltrexone (LDN)
According to the Low Dose Naltrexone home page [LDN], LDN has been seen to benefit
ankylosing spondylitis, which is considered to be an autoimmune disease.
[LDN] reports that all patients with autoimmune processes whom the late
Dr. Bihari [Bihari2003] treated using LDN "have experienced a halt in progression of their
illness.
In many patients there was a marked remission in signs and symptoms of the disease."
Dr. Bihari suggests a 50% to 70% overall response rate [Bihari2003].
Dr. Weyrich has been trained to use Low Dose Naltrexone (LDN).
However, Dr. Weyrich has not treated any cases of ankylosing spondylitis with LDN.
Please see
What is Low Dose Naltrexone?
for more information.
Neurotransmitter Balancing
Neuro Research [Hinz2015] reports that chronic diseases such as ankylosing spondylitis
can be benefited by balancing neurotransmitter levels in the body.
Dr. Weyrich has been trained in neurotransmitter balancing protocols, but has not treated
ankylosing spondylitis using this technique.
Please see What is Neurotransmitter Balancing?
for more information.